Articles related to PATIENT SAFETY

A series of cardiac emergencies without common treating physicians, nurses, or procedures raised red flags that ultimately led to the discovery of intentionally contaminated IV bags.

The expansion of this recall highlights the critical importance of verifying medication packaging against blister strip labeling, particularly for controlled substances where precise dosing is essential.

Mortality rates for hiatal hernia repairs vary significantly between elective (1.3%) and emergency (8%) procedures, emphasizing the importance of timely intervention when complications arise.

Adverse events from compounded semaglutide have led to hundreds of hospitalizations, highlighting critical safety concerns for healthcare providers managing patients seeking weight loss solutions.

The FDA-designated Class II recall affects specific duloxetine lots where exposure may lead to “temporary or medically reversible health consequences or where the probability of serious adverse health consequences is remote.”

Current evidence indicates that while digestive and energy improvements may manifest within one week, longer-term benefits require extended supplementation periods and careful monitoring of iodine levels.